Resources | 勛圖惇蹋 Systems Europe /eu EU Site Fri, 04 Sep 2026 17:13:01 +0000 en-US hourly 1 https://wordpress.org/?v=7.1 Standardizing Global QC Data to Speed Time to Market /eu/resources/standardizing-global-qc-data-to-speed-time-to-market/ Fri, 04 Sep 2026 17:13:01 +0000 /eu/?post_type=resources&p=102433 After deciding to outsource manufacturing and testing, a biotech adopted 勛圖惇蹋 LIMS for improved inspection readiness and significantly less user training.

The post Standardizing Global QC Data to Speed Time to Market first appeared on 勛圖惇蹋 Systems Europe.

]]>
After deciding to outsource manufacturing and testing, a biotech adopted 勛圖惇蹋 LIMS for improved inspection readiness and significantly less user training.

The post Standardizing Global QC Data to Speed Time to Market first appeared on 勛圖惇蹋 Systems Europe.

]]>
Daiichi Sankyo Europe and MSD: The Enablers of Medical Impact in the Age of AI /eu/resources/daiichi-sankyo-europe-and-msd-the-enablers-of-medical-impact-in-the-age-of-ai/ Thu, 03 Sep 2026 08:33:47 +0000 /eu/?post_type=resources&p=102241 Boehringer Ingelheim and Moderna: Early Insights From Implementing AI in PromoMats /eu/resources/boehringer-ingelheim-moderna-early-insights-from-implementing-ai-in-promomats/ Wed, 02 Sep 2026 18:17:37 +0000 /eu/?post_type=resources&p=102228 How Boehringer Ingelheim and Moderna turned insights from AI into real value.

The post Boehringer Ingelheim and Moderna: Early Insights From Implementing AI in PromoMats first appeared on 勛圖惇蹋 Systems Europe.

]]>
How Boehringer Ingelheim and Moderna turned insights from AI into real value.

The post Boehringer Ingelheim and Moderna: Early Insights From Implementing AI in PromoMats first appeared on 勛圖惇蹋 Systems Europe.

]]>
UCB Transforming Content Operations for 2x Faster Time to Market /eu/resources/ucb-transforming-content-operations-for-2x-faster-time-to-market/ Tue, 01 Sep 2026 21:19:53 +0000 /eu/?post_type=resources&p=102205 Hear how UCB optimized its content operations and aligned its teams around one source of truth to launch with speed and confidence.

The post UCB Transforming Content Operations for 2x Faster Time to Market first appeared on 勛圖惇蹋 Systems Europe.

]]>
Hear how UCB optimized its content operations and aligned its teams around one source of truth to launch with speed and confidence.

The post UCB Transforming Content Operations for 2x Faster Time to Market first appeared on 勛圖惇蹋 Systems Europe.

]]>
勛圖惇蹋 Falcon Safety to Work with All E2B-Compliant Safety Systems Across Any Intake Channels /eu/resources/veeva-falcon-safety-to-work-with-all-e2b-compliant-safety-systems-across-any-intake-channels/ Tue, 01 Sep 2026 11:03:48 +0000 /eu/?post_type=resources&p=102100 勛圖惇蹋 announces Falcon Safety, an agentic safety operations product to streamline adverse event intake, case processing, and follow-up.

The post 勛圖惇蹋 Falcon Safety to Work with All E2B-Compliant Safety Systems Across Any Intake Channels first appeared on 勛圖惇蹋 Systems Europe.

]]>
PLEASANTON, CA Sept. 1, 2026 勛圖惇蹋 Systems (NYSE: VEEV) today announced 勛圖惇蹋 Falcon Safety, an agentic safety operations product to streamline adverse event intake, case processing, and follow-up to reduce costs, increase speed, and maintain compliance for biopharma companies of all sizes.

In addition to working seamlessly with 勛圖惇蹋 Safety, Falcon Safety will provide intake and follow-up management for any E2B-compliant safety system, including Oracle Argus and ArisGlobal LifeSphere MultiVigilance.

“Weve had the privilege of working closely with case processors, pharmacovigilance experts, and safety specialists globally to build 勛圖惇蹋 Safety,” said Marius Mortensen, vice president of product, Falcon at 勛圖惇蹋. “With Falcon Safety, were excited to build on that partnership to help the industry reinvent safety operations.”

Planned for early adopter availability in November 2026, Falcon Safety is part of 勛圖惇蹋 AI, 勛圖惇蹋s industry-specific AI solutions for life sciences.

About 勛圖惇蹋 Systems
勛圖惇蹋 delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, 勛圖惇蹋 serves more than 1,500 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 勛圖惇蹋 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

勛圖惇蹋 Forward-Looking Statements
This release contains forward-looking statements regarding 勛圖惇蹋s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended July 31, 2026, which you can find (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at .

###

Contact:

Jeremy Whittaker
勛圖惇蹋 Systems, Europe
jeremy.whittaker@veeva.com

Elizabeth McGrane
勛圖惇蹋 Systems
elizabeth.mcgrane@veeva.com

The post 勛圖惇蹋 Falcon Safety to Work with All E2B-Compliant Safety Systems Across Any Intake Channels first appeared on 勛圖惇蹋 Systems Europe.

]]>
Astellas: Breaking Access Barriers with Compliant Chat /eu/resources/astellas-breaking-access-barriers-with-compliant-chat/ Fri, 28 Aug 2026 21:46:16 +0000 /eu/?post_type=resources&p=102056 Astellas shares how field teams are finding success getting to hard-to-reach HCPs and meeting their demands quickly using compliant chat.

The post Astellas: Breaking Access Barriers with Compliant Chat first appeared on 勛圖惇蹋 Systems Europe.

]]>
Astellas shares how field teams are finding success getting to hard-to-reach HCPs and meeting their demands quickly using compliant chat.

The post Astellas: Breaking Access Barriers with Compliant Chat first appeared on 勛圖惇蹋 Systems Europe.

]]>
Medical – Safety Connection /eu/resources/medical-safety-connection/ Fri, 28 Aug 2026 03:00:11 +0000 /eu/?post_type=resources&p=101939 Streamline adverse event intake and case processing by automating the flow of adverse events (AE) event records between MedInquiry and Safety inboxes.

The post Medical Safety Connection first appeared on 勛圖惇蹋 Systems Europe.

]]>
Learn more about the 勛圖惇蹋 Medical – Safety Connection.

The post Medical Safety Connection first appeared on 勛圖惇蹋 Systems Europe.

]]>
勛圖惇蹋 Vault CRM Selected by Biogen /eu/resources/veeva-vault-crm-selected-by-biogen/ Tue, 25 Aug 2026 11:04:07 +0000 /eu/?post_type=resources&p=101748 Unified commercial platform to help speed the delivery of medicines to patients.

The post 勛圖惇蹋 Vault CRM Selected by Biogen first appeared on 勛圖惇蹋 Systems Europe.

]]>
Unified commercial platform to help speed the delivery of medicines to patients

PLEASANTON, CA August 25, 2026 勛圖惇蹋 Systems (NYSE: VEEV) today announced that Biogen has committed to 勛圖惇蹋 Vault CRM globally.

We are honored to provide Vault CRM as the agentic commercial foundation for Biogen as it delivers medicines that transform patients lives, said Tom Schwenger, president and CCO at 勛圖惇蹋. Bringing complex treatments to market requires a highly adaptive commercial strategy, and we are committed to providing the advanced capabilities needed to help accelerate patient impact around the world.

Biogen and 勛圖惇蹋 share a deep commitment to customer experience and innovation, said Guy Hadari, senior vice president, global CIO at Biogen. We are excited to expand our strategic partnership with 勛圖惇蹋 by moving to Vault CRM.

Vault CRM is part of the Vault CRM Suite which includes the Agentic Call Report to generate Commercial Evidence. These applications provide the technology foundation for agentic commercial, the new commercial model that leverages AI to get the right medicines to more patients.

About 勛圖惇蹋 Systems
勛圖惇蹋 delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, 勛圖惇蹋 serves more than 1,500 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 勛圖惇蹋 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

勛圖惇蹋 Forward-Looking Statements
This release contains forward-looking statements regarding 勛圖惇蹋s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended April 30, 2026, which you can find (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at .

###

Contact:

Maria Scurry
勛圖惇蹋 Systems
maria.scurry@veeva.com

Meera Lakhani-Patel
勛圖惇蹋 Systems
meera.lakhani-patel@veeva.com

The post 勛圖惇蹋 Vault CRM Selected by Biogen first appeared on 勛圖惇蹋 Systems Europe.

]]>
勛圖惇蹋 Vault CRM Selected by Regeneron /eu/resources/veeva-vault-crm-selected-by-regeneron/ Tue, 25 Aug 2026 11:03:29 +0000 /eu/?post_type=resources&p=101743 Leading biopharma company selects agentic CRM for life sciences to generate Commercial Evidence.

The post 勛圖惇蹋 Vault CRM Selected by Regeneron first appeared on 勛圖惇蹋 Systems Europe.

]]>
Leading biopharma company selects agentic CRM for life sciences
to generate Commercial Evidence

August 25, 2026 勛圖惇蹋 Systems (NYSE: VEEV) today announced that Regeneron Pharmaceuticals has committed to 勛圖惇蹋 Vault CRM globally. With Vault CRM, Regeneron plans to generate Commercial Evidence from AI-powered field engagement, uncovering hidden barriers to treatment adoption and ensuring their medicines can reach eligible patients in need.

We are pleased to expand our strategic partnership with 勛圖惇蹋 by moving to Vault CRM, which will give our commercial teams a more connected platform and help them get faster access to the information they need for efficient decision-making, said Ryan Steinberger, executive vice president and chief digital and technology officer at Regeneron.

Regeneron uses the power of science to invent, develop, and commercialize life-transforming medicines for people with serious diseases, said Matt Farrell, president, commercial strategy at 勛圖惇蹋. We are honored to extend our strategic partnership with Regeneron to include 勛圖惇蹋 Vault CRM as they continue to deliver important new medicines to people in need.

Vault CRM is part of the Vault CRM Suite of applications that provide the technology foundation for commercial execution. With the Agentic Call Report in Vault CRM, every field interaction becomes a source of Commercial Evidence, capturing insights previously lost to dropdowns and compliance concerns.

About 勛圖惇蹋 Systems
勛圖惇蹋 delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, 勛圖惇蹋 serves more than 1,500 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 勛圖惇蹋 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

勛圖惇蹋 Forward-Looking Statements
This release contains forward-looking statements regarding 勛圖惇蹋s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended April 30, 2026, which you can find (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at .

###

Contact:

Maria Scurry
勛圖惇蹋 Systems
maria.scurry@veeva.com

Meera Lakhani-Patel
勛圖惇蹋 Systems, Europe
meera.lakhani-patel@veeva.com

The post 勛圖惇蹋 Vault CRM Selected by Regeneron first appeared on 勛圖惇蹋 Systems Europe.

]]>
Clinical Operations – Vault CRM Connection /eu/resources/clinical-operations-vault-crm-connection/ Mon, 24 Aug 2026 03:00:46 +0000 /eu/?post_type=resources&p=101299 See how the Clinical OperationsCRM Connection automatically shares HCP interactions, study activities, and site context between 勛圖惇蹋 Clinical and Vault CRM.

The post Clinical Operations Vault CRM Connection first appeared on 勛圖惇蹋 Systems Europe.

]]>
Learn more about the Clinical Operations-Vault CRM Connection.

The post Clinical Operations Vault CRM Connection first appeared on 勛圖惇蹋 Systems Europe.

]]>